Allogene Therapeutics Competitors and Similar CompaniesClear all

Allogene Therapeutics's competitors and similar companies include Bellicum Pharmaceuticals, Plus Therapeutics, Gilead Sciences, Novartis, Amgen and Cellectis.
Allogene Therapeutics
Allogene Therapeutics
Allogene Therapeutics is a clinical-stage biotechnology company developing allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer.
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals is a biopharmaceutical company focused on discovering and developing cellular immunotherapies.
Plus Therapeutics
Plus Therapeutics
Plus Therapeutics is a pharmaceutical company focused on the development of treatments for patients battling cancer and other life-threatening diseases.
Gilead Sciences
Gilead Sciences
Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines.
Novartis
Novartis
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
Amgen
Amgen
Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics.
Cellectis
Cellectis
Cellectis is a biopharmaceutical company focused on developing develop a new generation of cancer immunotherapies based on engineered allogeneic T-cells.
Founding Date
Founding Date
2018
Founding Date
2004
Founding Date
1996
Founding Date
1987
Founding Date
1996
Founding Date
1980
Founding Date
1999
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
South San Francisco, US HQ
Locations
Houston, US HQ
Houston, US
Houston, US
South San Francisco, US
Locations
Austin, US HQ
San Antonio, US
Locations
Foster City, US HQ
Buenos Aires, AR
Melbourne, AU
Wien, AT
Machelen, BE
São Paulo, BR
Edmonton, CA
see more
Locations
Basel, CH HQ
Tirana, AL
Buenos Aires, AR
Macquarie Park, AU
Kundl, AT
Unterlangkampfen, AT
Wien, AT
see more
Locations
Thousand Oaks, US HQ
Hydra, DZ
Vicente López, AR
Sydney, AU
Wien, AT
Diegem, BE
Santo Amaro, BR
see more
Locations
Paris, FR HQ
Lyon, FR
New York, US
Raleigh, US
Employees
Employees
35917% increase
Employees
1386% increase
Employees
1721% increase
Employees
18,0006% increase
Employees
76,057
Employees
25,200
Employees
231
Valuation ($)
Valuation ($)
495.5 m
Valuation ($)
778.3 k
Valuation ($)
9.4 m
Valuation ($)
81.8 b
Valuation ($)
N/A
Valuation ($)
164.4 b
Valuation ($)
215.7 m
Twitter followers
Twitter followers
2.2 k
Twitter followers
588
Twitter followers
563
Twitter followers
73.8 k
Twitter followers
301.8 k
Twitter followers
123.5 k
Twitter followers
4.6 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
8
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
6
Number of tweets (last 30 days)
22
Number of tweets (last 30 days)
4
Number of tweets (last 30 days)
91
Number of tweets (last 30 days)
2
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
3.1
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
2.3
Average likes per tweet (last 30 days)
48.1
Average likes per tweet (last 30 days)
8.5
Average likes per tweet (last 30 days)
4.8
Average likes per tweet (last 30 days)
5
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
75%
Percentage of tweets with engagement (last 30 days)
97.8%
Percentage of tweets with engagement (last 30 days)
100%

Financial

Revenue (est.)
Revenue (est.)
$243k (FY, 2022)
Revenue (est.)
$1.5m (FY, 2022)
Revenue (est.)
N/A
Revenue (est.)
$27.1b (FY, 2023)
Revenue (est.)
$54.1b (FY, 2023)
Revenue (est.)
$28.2b (FY, 2023)
Revenue (est.)
$19.3m (FY, 2022)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$6.5b (FY, 2023)
Cost of goods
$8.2b (FY, 2023)
Cost of goods
$8.5b (FY, 2023)
Cost of goods
$1.8m (FY, 2022)
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
N/A
Gross profit
$20.6b (FY, 2023)
Gross profit
$47.7b (FY, 2023)
Gross profit
$19.7b (FY, 2023)
Gross profit
$25.9m (FY, 2022)
Net income
Net income
($332.6m) (FY, 2022)
Net income
($25m) (FY, 2022)
Net income
($13.3m) (FY, 2023)
Net income
$5.6b (FY, 2023)
Net income
$9b (FY, 2023)
Net income
$6.7b (FY, 2023)
Net income
($114m) (FY, 2022)

Operating

Countries
Countries
N/A
Countries
N/A
Countries
N/A
Countries
35 (FY, 2021)
Countries
N/A
Countries
100 (FY, 2020)
Countries
N/A
Phase I Trials Products
Phase I Trials Products
4 (FY, 2019)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
20 (FY, 2020)
Phase I Trials Products
N/A
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
9 (FY, 2021)
Phase III Trials Products
44 (FY, 2022)
Phase III Trials Products
11 (FY, 2020)
Phase III Trials Products
N/A
Phase III Trials Products (Oncology)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
4 (FY, 2021)
Phase III Trials Products (Oncology)
27 (FY, 2021)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A

Funding

Total funding raised
Total funding raised
$ 532m
Total funding raised
N/A
Total funding raised
$ 71.9m
Total funding raised
N/A
Total funding raised
$ 6.5m
Total funding raised
N/A
Total funding raised
$ 3.2m
For sources of this data, please see the company profile

View Company Profiles

Bellicum Pharmaceuticals
HQ
Houston, US
Employees
13

Bellicum Pharmaceuticals is a biopharmaceutical company focused on discovering and developing cellular immunotherapies.

View company
Plus Therapeutics
HQ
Austin, US
Employees
17↑ 21% increase

Plus Therapeutics is a pharmaceutical company focused on the development of treatments for patients battling cancer and other life-threatening diseases.

View company
Gilead Sciences
HQ
Foster City, US
Employees
18,000↑ 6% increase

Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines.

View company
Novartis
HQ
Basel, CH
Employees
76,057

Novartis is a company that researches, develops, manufactures, and markets healthcare products.

View company